A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.
Media Relations Manager (Enterprise)
T: 020 7679 9063
Henry is responsible for media
relations for enterprise activity across UCL, including student and staff
entrepreneurship, corporate partnerships, business support, commercialisation
of research and spinouts. He joined the team at the beginning of 2012, having
previously worked as a press officer at Friends of the Earth and the Royal
Geographical Society (with IBG). Henry has a BA (Hons) in Geography from the University of Oxford.